• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. GWEL MARK ULTRA MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. GWEL MARK ULTRA MARKER Back to Search Results
Catalog Number UNK GELMARK
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
It was reported that following three different stereotactic breast biopsy procedures performed over several weeks time frame, the marker was placed into the breast under compression and during the post mammogram, it was discovered that the marker had migrated.One of the patients was taken back to the procedure room, and another marker was placed under ultrasound guidance; however the other two patients did not receive another clip/marker.The migration of the clip was documented in their files.There was no patient injury reported.
 
Manufacturer Narrative
After further clinical review of this event with bard's medical department, this event was reassessed and determined to be mdr reportable as a malfunction pursuant to 21 cfr part 803.A manufacturing review was conducted and the reported lot met all release criteria.This is the first complaint for this lot number and issue to date.The investigation is inconclusive, as the sample was not returned for evaluation.It is unknown if patient and/or procedural issues contributed to the reported event.Based on the available information, the definitive root cause is unknown.The current gel mark ultra breast biopsy marker instructions for use (ifu) provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.A-d: the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GWEL MARK ULTRA MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
tempe AZ
Manufacturer (Section G)
SENORX, INC.
3 morgan
irvine CA 92618 191
Manufacturer Contact
linda morocho
1625 west 3rd st.
tempe, AZ 85281
4808949515
MDR Report Key4909765
MDR Text Key6052420
Report Number2020394-2015-00949
Device Sequence Number1
Product Code FZP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK GELMARK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/10/2015
Initial Date FDA Received06/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-